Lataa...

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Allogeneic blood or marrow transplantation (BMT) candidates may lack HLA-matched, related haploidentical, and unrelated umbilical cord options. Barriers to partially HLA-mismatched, unrelated donor (mMUD) BMT include excess graft-versus-host disease (GVHD), graft failure, and death. We prospectively...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Adv
Päätekijät: Kasamon, Yvette L., Ambinder, Richard F., Fuchs, Ephraim J., Zahurak, Marianna, Rosner, Gary L., Bolaños-Meade, Javier, Levis, Mark J., Gladstone, Douglas E., Huff, Carol Ann, Swinnen, Lode J., Matsui, William H., Borrello, Ivan, Brodsky, Robert A., Jones, Richard J., Luznik, Leo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5726600/
https://ncbi.nlm.nih.gov/pubmed/29242852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016002766
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!